Bajin Wei
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
Papers in
-
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 6
- Epigenetics and DNA Methylation 4
- Oncology 14
- Cancer-related Molecular Pathways 3
- Global Cancer Incidence and Screening 3
- Co-authors
- Chunyang Xing (6 shared papers)Peifen Fu (3 shared papers)Minya Yao (3 shared papers)Yu Liu (2 shared papers)Zhijun Dai (12 shared papers)Haiyang Xie (10 shared papers)Yujiao Deng (10 shared papers)Shuqian Wang (5 shared papers)
- Journals
- Frontiers in Oncology (4 papers)OncoTargets and Therapy (2 papers)Journal of Translational Medicine (2 papers)Molecular Cancer Therapeutics (1 paper)JAMA Network Open (1 paper)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Bajin Wei
30 papers receiving 830 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 202
- Oncology 357
- Cell Biology 92
- Molecular Biology 324
- Immunology 99
Countries citing papers authored by Bajin Wei
This map shows the geographic impact of Bajin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bajin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bajin Wei more than expected).
Fields of papers citing papers by Bajin Wei
This network shows the impact of papers produced by Bajin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bajin Wei. The network helps show where Bajin Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bajin Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 141 | |
| 2 | 2016 | 116 | |
| 3 | 2014 | 75 | |
| 4 | 2022 | 68 | |
| 5 | 2021 | 48 | |
| 6 | 2012 | 46 | |
| 7 | 2012 | 40 | |
| 8 | 2018 | 37 | |
| 9 | 2022 | 35 | |
| 10 | 2021 | 26 | |
| 11 | 2012 | 23 | |
| 12 | 2021 | 21 | |
| 13 | 2020 | 21 | |
| 14 | 2020 | 21 | |
| 15 | Tracheal, bronchus, and lung cancer burden and related risk factors in the United States and China. | 2021 | 16 |
| 16 | 2021 | 12 | |
| 17 | 2013 | 12 | |
| 18 | 2021 | 11 | |
| 19 | 2013 | 11 | |
| 20 | 2024 | 8 |
About Bajin Wei
Bajin Wei is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 32 papers that have together received 832 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related Molecular Pathways (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Cancer Research (202 citations), Oncology (357 citations), Cell Biology (92 citations), Molecular Biology (324 citations) and Immunology (99 citations). Bajin Wei has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Chunyang Xing, Peifen Fu, Minya Yao, Yu Liu, Zhijun Dai, Haiyang Xie, Yujiao Deng, Shuqian Wang, Lin Zhou and Shusen Zheng. Their work appears in journals such as Frontiers in Oncology, OncoTargets and Therapy, Journal of Translational Medicine, Molecular Cancer Therapeutics and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.